Innoblative Designs
Pre-clinicalInnoblative Designs is addressing unmet clinical needs for patients with breast cancer and other soft tissue diseases, received Breakthrough Device Designation from the FDA for the company's SIRA® RFA Electrosurgical Device.
Founded
2019
Focus
Medical DevicesOncology
About
Innoblative Designs is addressing unmet clinical needs for patients with breast cancer and other soft tissue diseases, received Breakthrough Device Designation from the FDA for the company's SIRA® RFA Electrosurgical Device.
Funding History
2Total raised: $4.5M
Seed$4MUndisclosedMay 15, 2023
Grant$500KNational Institutes of HealthAug 15, 2022
Company Info
TypePrivate
Founded2019
LocationSan Francisco, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile